Your browser doesn't support javascript.
loading
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer.
Galan, Alba; Papaluca, Arturo; Nejatie, Ali; Matanes, Emad; Brahimi, Fouad; Tong, Wenyong; Hachim, Ibrahim Yaseen; Yasmeen, Amber; Carmona, Euridice; Klein, Kathleen Oros; Billes, Sonja; Dawod, Ahmed E; Gawande, Prasad; Jeter, Anna Milik; Mes-Masson, Anne-Marie; Greenwood, Celia M T; Gotlieb, Walter H; Saragovi, H Uri.
Afiliación
  • Galan A; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Papaluca A; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Nejatie A; Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
  • Matanes E; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Brahimi F; Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
  • Tong W; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Hachim IY; Department of Ob-Gyn, Jewish General Hospital, McGill University and Segal Cancer Center, Lady Davis Institute of Medical Research, Montreal, QC, Canada.
  • Yasmeen A; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Carmona E; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Klein KO; Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
  • Billes S; Clinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
  • Dawod AE; Department of Ob-Gyn, Jewish General Hospital, McGill University and Segal Cancer Center, Lady Davis Institute of Medical Research, Montreal, QC, Canada.
  • Gawande P; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du Cancer de Montréal, Montreal, QC, Canada.
  • Jeter AM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Université de Montréal, Montreal, QC, Canada.
  • Mes-Masson AM; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
  • Greenwood CMT; R&D Department, AOA Dx Inc, Cambridge, MA, United States.
  • Gotlieb WH; R&D Department, AOA Dx Inc, Cambridge, MA, United States.
  • Saragovi HU; R&D Department, AOA Dx Inc, Cambridge, MA, United States.
Front Oncol ; 13: 1134763, 2023.
Article en En | MEDLINE | ID: mdl-37124505
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza